Journal article icon

Journal article

Rotavirus immunization: Global coverage and local barriers for implementation

Abstract:

Background

Rotavirus (RV) is a major agent of gastroenteritis and an important cause of child death worldwide. Immunization (RVI) has been available since 2006. the Federation of International Societies of Gastroenterology Hepatology and Nutrition (FISPGHAN) identified RVI as a top priority for the control of diarrheal illness. A FISPGHAN working group on acute diarrhea aimed at estimating the current RVI coverage and identifying barriers to implementation worldwide.

Methods

A survey was distributed to national experts in infectious diseases and vaccinations, and health-care authorities (March 2015 -April 2016), collecting information on local recommendations, costs and perception of barriers to implementation.

Findings

RVI is recommended in 27/49 countries (55%) participating in the survey. Although five countries have recommended RVI since 2006, a large number (16, 33%) included RVI in a National Immunization Schedule between 2012 and 2014. The costs of vaccination are covered by the government (39%), by the GAVI Alliance (10%) or public and private insurance (8%) in some countries. However, in most cases, immunization is paid by families (43%). Elevated costs (49%) and the limited perception of RV illness severity by the families (47%) and public-health authorities (37%) are the major barriers to large-scale RVI programs.

Interpretation

After 10 years since its introduction, the implementation of RVI is still unacceptably low and should remain a major target for global public health. Barriers to implementation vary according to setting. Nevertheless, public health authorities should promote education for caregivers and health-care providers and interact with local health authorities in order to implement RVI

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1016/j.vaccine.2017.01.082

Authors


More by this author
Institution:
University of Oxford
Oxford college:
Nuffield College
Role:
Author


Publisher:
Elsevier
Journal:
Vaccine More from this journal
Volume:
35
Issue:
12
Pages:
1637-1644
Publication date:
2017-02-01
Acceptance date:
2017-01-27
DOI:
ISSN:
0264-410X and 1873-2518


Keywords:
Pubs id:
pubs:684183
UUID:
uuid:f6c12fbc-0b8a-4931-9e87-8e9202519d61
Local pid:
pubs:684183
Source identifiers:
684183
Deposit date:
2017-04-04

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP